1 year return (CAGR)
-36.13%
Innate Pharma Exchange (NASDAQ, USD)
IPHA
1.52
+0.04 (+2.70%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-15.28%
5 year return (CAGR)
-22.79%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
169.78M
Price/Sales
43.86
Ent value
238.53M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.21%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.53 |
| Daily high | 1.57 |
| Daily low | 1.52 |
| Daily Volume | 2K |
| All-time high | 8.20 |
| 1y analyst estimate | 6.67 |
| Beta | 0.88 |
| EPS (TTM) | -1.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Mar 2026 |
Downside potential
Loading...
Downside potential data
| IPHA | S&P500 | |
| Current price drop from All-time high | -81.46% | -0.87% |
| Highest price drop | -85.73% | -56.47% |
| Date of highest drop | 20 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -58.93% | -10.65% |
| Avg time to new high | 110 days | 12 days |
| Max time to new high | 1626 days | 1805 days |
News
